SCHEMBL29937752

SCHEMBL29937752

NC(=O)C(c1ccccc1)c1cccnc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.55
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
CFTR P13569 1/20 0.53
SLC6A2 P23975 1/20 0.53
SLC6A4 P31645 1/20 0.53
SLC6A3 Q01959 1/20 0.53
GOPC Q9HD26 1/20 0.53
TBXAS1 P24557 1/20 0.48
KCNA5 P22460 3/20 0.47
KCNN4 O15554 2/20 0.47
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
SARM1 Q6SZW1 1/20 0.47
SIRT2 Q8IXJ6 1/20 0.47
SIRT6 Q8N6T7 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
SIRT3 Q9NTG7 1/20 0.47
SIRT5 Q9NXA8 1/20 0.47
SIRT4 Q9Y6E7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198036 1.00 ALDH1A1 (0.55) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL362393 0.94 F7 (0.52) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL3057993 0.92 MKNK1 (0.50) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL4534187 0.85 SMN1; SMN2 (0.58) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL2205442 0.83 SLC6A2 (0.54) ALDH1A1HTTSLC6A2SLC6A4SLC6A3
SCHEMBL741751 0.82 MEN1 (0.58) SMN1; SMN2LMNA
SCHEMBL2815738 0.82 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL14284024 0.82 SMN1; SMN2 (0.55) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL10634303 0.81 KCNA5 (0.46) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2
SCHEMBL306372 0.81 F7 (0.53) ALDH1A1HTTSMN1; SMN2CFTRSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226203-A1 PROTEASE INHIBITORS AND METHODS OF USE THE CLEVELAND CLINIC FOUNDATION (US) 2022-10-27 WO disclosed